Catamaran Corp (CTRX) 53.24 $CTRX
Catamaran to host 2014 fourth quarter and year-end conference call
CNW Group - Thu Feb 12, 10:00AM CST
Catamaran (NASDAQ: CTRX) (TSX: CCT) announces that it will release its fiscal 2014 fourth quarter and year-end financial results on Thursday, February 26, 2015, at 6:00 AM Eastern Time. The Company will hold a conference call at 8:30 AM Eastern Time that same day, Thursday, February 26, 2015, hosted by Mark Thierer, Chairman and CEO, and Mike Shapiro, Senior Vice President and CFO.
CTRX: 53.24 (+0.65), CCT.TO: 66.31 (+0.61)
Independent Pharmacies File Suit Against Pharmacy Benefit Manager Catamaran, Claiming Illegal Conduct and Calling for a Jury Trial
PR Newswire - Thu Feb 12, 9:38AM CST
Fifty-five independent pharmacies hailing primarily from Pennsylvania filed suit this week in the U.S. District Court for the Middle District of Pennsylvania(1) against pharmacy benefit manager ("PBM"
Catamaran Corporation, formerly known as SXC Health Solutions. Catamaran's annual revenue is nearly $15 billion, managing 350 million patient prescriptions per year.(2)
CTRX: 53.24 (+0.65)
Boston Scientific (BSX) Poised for Strong Earnings in Q4 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Feb 03, 12:00PM CST
We expect Boston Scientific Corporation (BSX) to beat expectations when it reports fourth-quarter and fiscal 2014 results before the opening bell on Feb 4.
BSX: 14.98 (+0.24), CTRX: 53.24 (+0.65), PDCO: 50.65 (-0.16), HLS: 45.01 (+0.30)
Catamaran Introducing Innovative Clinical Outcomes-Based Program for Hepatitis C Treatment
CNW Group - Tue Feb 03, 11:31AM CST
- Company Selects Gilead Sciences as its Exclusive Hepatitis C Treatment Provider - - Program Offered Exclusively Through Company's Specialty Pharmacy, BriovaRx(® )-
CTRX: 53.24 (+0.65), GILD: 101.90 (+1.10), CCT.TO: 66.31 (+0.61)
Update: Catamaran's Acquisition Of Salveo Specialty Pharmacy
Real Estater - at Seeking Alpha - Wed Jan 28, 11:54AM CST
CTRX: 53.24 (+0.65)
Technical Snapshot on Health Care Services Stocks -- Express Scripts Holding, Quest Diagnostics, Laboratory Corp. of America, Catamaran, and DaVita HealthCare Partners
PR Newswire - Wed Jan 21, 7:30AM CST
Investor-Edge has initiated coverage on the following equities: Express Scripts Holding Company (NASDAQ: ESRX), Quest Diagnostics Inc. (NYSE: DGX), Laboratory Corporation of America Holdings (NYSE: LH), Catamaran Corporation (NASDAQ: CTRX), and DaVita HealthCare Partners Inc. (NYSE: DVA). Free research report on Express Scripts Holding can be accessed at http://get.Investor-Edge.com/pdf/?c=Express%2...amp;s=ESRX. On Tuesday, January 20, 2015, the NASDAQ Composite ended at 4,654.85, up 0.44%, the Dow Jones Industrial Average advanced 0.02%, to finish the day at 17,515.23, and the S&P 500 closed at 2,022.55, up 0.15%. The gains were broad based as seven out of ten sectors ended the session in positive. The S&P 500 Health Care Sector Index ended the day at 814.01, down 0.08%, while the index has advanced 14.99% in the previous three months. Register for your complimentary reports at the links given below.
CTRX: 53.24 (+0.65), ESRX: 84.90 (+0.40), DVA: 73.10 (-3.29), DGX: 71.68 (+0.03), LH: 116.90 (+0.06)
1 Big Loser in the Slugfest Between AbbVie and Gilead Sciences
Keith Speights, The Motley Fool - Motley Fool - Mon Jan 12, 8:03AM CST
Source: Wikimedia Commons An epic fight is under way in the world of hepatitis C. We've seen a couple of punches thrown just over the last few days. The latest occurred on Thursday with Anthem 's selection of Gilead Sciences ' Harvoni as a...
ANTM: 141.05 (-0.95), ESRX: 84.90 (+0.40), CTRX: 53.24 (+0.65), JPM: 59.67 (+0.10), GILD: 101.90 (+1.10), CVS: 102.63 (-0.37), ABBV: 58.05 (+1.00), MS: 36.78 (-0.12)
BioTelemetry Raised to Strong Buy on Pipeline Strength - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jan 07, 9:00AM CST
On Jan 6, 2014, Zacks Investment Research upgraded BioTelemetry, Inc. (BEAT) to a Zacks Rank #1 (Strong Buy)
BGMD: 0.88 (unch), CTRX: 53.24 (+0.65), ABCO: 53.69 (+0.32), BEAT: 10.36 (+0.20)
Trade-Ideas: Catamaran (CTRX) Is Today's "Water-Logged And Getting Wetter" Stock
at The Street - Mon Jan 05, 1:14PM CST
Trade-Ideas LLC identified Catamaran (CTRX) as a "water-logged and getting wetter" (weak stocks crossing below support with today's range greater than 200%) candidate
CTRX: 53.24 (+0.65)
Catamaran acquires Salveo Specialty Pharmacy
M2 - Mon Jan 05, 10:49AM CST
Catamaran Corp. (NASDAQ: CTRX)(TSX: CCT) said it has completed its acquisition of Salveo Specialty Pharmacy, for a purchase price of USD260 million in cash.
CTRX: 53.24 (+0.65), CCT.TO: 66.31 (+0.61)
Catamaran to Present at the 33rd Annual J.P. Morgan Healthcare Conference
CNW Group - Mon Jan 05, 7:00AM CST
Catamaran Corp. (NASDAQ: CTRX) (TSX: CCT), a leading provider of technology and pharmacy benefit management (PBM) services, announces that Mark Thierer, Chief Executive Officer, and Mike Shapiro, Chief Financial Officer, will present at the 33rd Annual J.P. Morgan Healthcare Conference in San Francisco, CA. Catamaran's presentation will take place on Monday, January 12, 2015, at 12:00 p.m. ET.
CTRX: 53.24 (+0.65), JPM: 59.67 (+0.10), CCT.TO: 66.31 (+0.61)
Catamaran Completes Acquisition of Salveo Specialty Pharmacy
CNW Group - Mon Jan 05, 5:00AM CST
Catamaran Corp. (NASDAQ: CTRX, TSX: CCT), a leading provider of pharmacy benefit management (PBM) services and technology solutions, announced today the completion, effective as of January 2, 2015, of its previously disclosed acquisition of Salveo Specialty Pharmacy, for a purchase price of $260 million in cash, subject to certain customary post-closing adjustments. The purchase price was funded from Catamaran's existing cash balance.
CTRX: 53.24 (+0.65), CCT.TO: 66.31 (+0.61)
Omnicare (OCR) Faces Another Kickback Allegation - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Dec 30, 4:05PM CST
Healthcare services company, Omnicare Inc. (OCR) is facing charges of receiving kickbacks from Abbott Laboratories.
ABT: 46.09 (+0.87), CTRX: 53.24 (+0.65), OCR: 76.89 (+0.14), AHS: 20.56 (-0.34)
Doug Loe: Canada Has Earned Its Spot In The Biotech All-Star Team Photo
Life Sciences Report - Seeking Alpha - Fri Dec 19, 9:53AM CST
Biotech investors in the United States who overlook investment opportunities across the borders are missing out on huge opportunities, says Douglas Loe, healthcare equity analyst with Euro Pacific Canada. In this interview with The Life Sciences...
BIIB: 391.66 (-0.45), VRX: 167.00 (-0.50), QLTI: 4.15 (unch), CTRX: 53.24 (+0.65), BCRX: 10.06 (-0.09), ACT: 285.37 (+3.71), MDT: 75.26 (+0.33), TKMR: 21.45 (-0.22), NEPT: 1.83 (+0.06), BSX: 14.98 (+0.24), AGN: 229.49 (+1.87), CMRX: 40.16 (+0.08), ALNY: 95.54 (+1.67), SRPT: 12.76 (+0.11), SHPG: 239.82 (+6.11), NLNK: 38.84 (+1.51), SNY: 49.42 (+0.82), MSLI: 1.96 (+0.08), NVCN: 9.08 (-0.17), CRME: 9.76 (-0.14), EBS: 28.76 (-0.12), GSK: 47.94 (+1.99), CELG: 115.88 (+0.16), GILD: 101.90 (+1.10), MRK: 58.81 (-0.07), NVDQ: 15.12 (+0.51), NVS: 102.20 (-0.17)
Health Care Services Equities Technical Commentary - Express Scripts Holding, DaVita HealthCare Partners, Omnicare, Laboratory Corp. of America, and Catamaran
PR Newswire - Mon Dec 08, 7:45AM CST
Investor-Edge has initiated coverage on the following equities: Express Scripts Holding Company (NASDAQ:ESRX), DaVita HealthCare Partners Inc. (NYSE: DVA), Omnicare Inc. (NYSE: OCR), Laboratory Corporation of America Holdings (NYSE: LH), and Catamaran Corporation (NASDAQ: CTRX). Free research on these five companies can be accessed at: http://investor-edge.com/register. On Friday, December 05, 2014, the NASDAQ Composite ended at 4,780.76, up 0.24%, the Dow Jones Industrial Average advanced 0.33%, to finish the day at 17,958.79, and the S&P 500 closed at 2,075.37, up 0.17%. During the session five out of ten sectors ended in positive. The S&P 500 Health Care Sector Index ended the day at 817.34, up 0.77%, with the index also advancing 5.43% in the last one month. Register for your complimentary reports on these five stocks at:
CTRX: 53.24 (+0.65), OCR: 76.89 (+0.14), ESRX: 84.90 (+0.40), DVA: 73.10 (-3.29), LH: 116.90 (+0.06)
Catamaran to present at the Bank of America Merrill Lynch 2014 Leveraged Finance Conference
PR Newswire - Wed Nov 26, 7:15AM CST
Catamaran Corp. (NASDAQ: CTRX) (TSX: CCT), a leading provider of technology and pharmacy benefit management (PBM) services, announces that Mike Shapiro, Chief Financial Officer, will present at the Bank of America Merrill Lynch 2014 Leveraged Finance Conference in Boca Raton, FL. Catamaran's presentation will take place on Wednesday, December 3, 2014, at 8:10 a.m. ET.
CTRX: 53.24 (+0.65), CCT.TO: 66.31 (+0.61)
Catamaran to host 2014 fourth quarter and year-end conference call
CNW Group - Thu Feb 12, 10:00AM CST
Catamaran (NASDAQ: CTRX) (TSX: CCT) announces that it will release its fiscal 2014 fourth quarter and year-end financial results on Thursday, February 26, 2015, at 6:00 AM Eastern Time. The Company will hold a conference call at 8:30 AM Eastern Time that same day, Thursday, February 26, 2015, hosted by Mark Thierer, Chairman and CEO, and Mike Shapiro, Senior Vice President and CFO.
CTRX: 53.24 (+0.65), CCT.TO: 66.31 (+0.61)
Independent Pharmacies File Suit Against Pharmacy Benefit Manager Catamaran, Claiming Illegal Conduct and Calling for a Jury Trial
PR Newswire - Thu Feb 12, 9:38AM CST
Fifty-five independent pharmacies hailing primarily from Pennsylvania filed suit this week in the U.S. District Court for the Middle District of Pennsylvania(1) against pharmacy benefit manager ("PBM"
Catamaran Corporation, formerly known as SXC Health Solutions. Catamaran's annual revenue is nearly $15 billion, managing 350 million patient prescriptions per year.(2) CTRX: 53.24 (+0.65)
Boston Scientific (BSX) Poised for Strong Earnings in Q4 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Feb 03, 12:00PM CST
We expect Boston Scientific Corporation (BSX) to beat expectations when it reports fourth-quarter and fiscal 2014 results before the opening bell on Feb 4.
BSX: 14.98 (+0.24), CTRX: 53.24 (+0.65), PDCO: 50.65 (-0.16), HLS: 45.01 (+0.30)
Catamaran Introducing Innovative Clinical Outcomes-Based Program for Hepatitis C Treatment
CNW Group - Tue Feb 03, 11:31AM CST
- Company Selects Gilead Sciences as its Exclusive Hepatitis C Treatment Provider - - Program Offered Exclusively Through Company's Specialty Pharmacy, BriovaRx(® )-
CTRX: 53.24 (+0.65), GILD: 101.90 (+1.10), CCT.TO: 66.31 (+0.61)
Update: Catamaran's Acquisition Of Salveo Specialty Pharmacy
Real Estater - at Seeking Alpha - Wed Jan 28, 11:54AM CST
CTRX: 53.24 (+0.65)
Technical Snapshot on Health Care Services Stocks -- Express Scripts Holding, Quest Diagnostics, Laboratory Corp. of America, Catamaran, and DaVita HealthCare Partners
PR Newswire - Wed Jan 21, 7:30AM CST
Investor-Edge has initiated coverage on the following equities: Express Scripts Holding Company (NASDAQ: ESRX), Quest Diagnostics Inc. (NYSE: DGX), Laboratory Corporation of America Holdings (NYSE: LH), Catamaran Corporation (NASDAQ: CTRX), and DaVita HealthCare Partners Inc. (NYSE: DVA). Free research report on Express Scripts Holding can be accessed at http://get.Investor-Edge.com/pdf/?c=Express%2...amp;s=ESRX. On Tuesday, January 20, 2015, the NASDAQ Composite ended at 4,654.85, up 0.44%, the Dow Jones Industrial Average advanced 0.02%, to finish the day at 17,515.23, and the S&P 500 closed at 2,022.55, up 0.15%. The gains were broad based as seven out of ten sectors ended the session in positive. The S&P 500 Health Care Sector Index ended the day at 814.01, down 0.08%, while the index has advanced 14.99% in the previous three months. Register for your complimentary reports at the links given below.
CTRX: 53.24 (+0.65), ESRX: 84.90 (+0.40), DVA: 73.10 (-3.29), DGX: 71.68 (+0.03), LH: 116.90 (+0.06)
1 Big Loser in the Slugfest Between AbbVie and Gilead Sciences
Keith Speights, The Motley Fool - Motley Fool - Mon Jan 12, 8:03AM CST
Source: Wikimedia Commons An epic fight is under way in the world of hepatitis C. We've seen a couple of punches thrown just over the last few days. The latest occurred on Thursday with Anthem 's selection of Gilead Sciences ' Harvoni as a...
ANTM: 141.05 (-0.95), ESRX: 84.90 (+0.40), CTRX: 53.24 (+0.65), JPM: 59.67 (+0.10), GILD: 101.90 (+1.10), CVS: 102.63 (-0.37), ABBV: 58.05 (+1.00), MS: 36.78 (-0.12)
BioTelemetry Raised to Strong Buy on Pipeline Strength - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jan 07, 9:00AM CST
On Jan 6, 2014, Zacks Investment Research upgraded BioTelemetry, Inc. (BEAT) to a Zacks Rank #1 (Strong Buy)
BGMD: 0.88 (unch), CTRX: 53.24 (+0.65), ABCO: 53.69 (+0.32), BEAT: 10.36 (+0.20)
Trade-Ideas: Catamaran (CTRX) Is Today's "Water-Logged And Getting Wetter" Stock
at The Street - Mon Jan 05, 1:14PM CST
Trade-Ideas LLC identified Catamaran (CTRX) as a "water-logged and getting wetter" (weak stocks crossing below support with today's range greater than 200%) candidate
CTRX: 53.24 (+0.65)
Catamaran acquires Salveo Specialty Pharmacy
M2 - Mon Jan 05, 10:49AM CST
Catamaran Corp. (NASDAQ: CTRX)(TSX: CCT) said it has completed its acquisition of Salveo Specialty Pharmacy, for a purchase price of USD260 million in cash.
CTRX: 53.24 (+0.65), CCT.TO: 66.31 (+0.61)
Catamaran to Present at the 33rd Annual J.P. Morgan Healthcare Conference
CNW Group - Mon Jan 05, 7:00AM CST
Catamaran Corp. (NASDAQ: CTRX) (TSX: CCT), a leading provider of technology and pharmacy benefit management (PBM) services, announces that Mark Thierer, Chief Executive Officer, and Mike Shapiro, Chief Financial Officer, will present at the 33rd Annual J.P. Morgan Healthcare Conference in San Francisco, CA. Catamaran's presentation will take place on Monday, January 12, 2015, at 12:00 p.m. ET.
CTRX: 53.24 (+0.65), JPM: 59.67 (+0.10), CCT.TO: 66.31 (+0.61)
Catamaran Completes Acquisition of Salveo Specialty Pharmacy
CNW Group - Mon Jan 05, 5:00AM CST
Catamaran Corp. (NASDAQ: CTRX, TSX: CCT), a leading provider of pharmacy benefit management (PBM) services and technology solutions, announced today the completion, effective as of January 2, 2015, of its previously disclosed acquisition of Salveo Specialty Pharmacy, for a purchase price of $260 million in cash, subject to certain customary post-closing adjustments. The purchase price was funded from Catamaran's existing cash balance.
CTRX: 53.24 (+0.65), CCT.TO: 66.31 (+0.61)
Omnicare (OCR) Faces Another Kickback Allegation - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Dec 30, 4:05PM CST
Healthcare services company, Omnicare Inc. (OCR) is facing charges of receiving kickbacks from Abbott Laboratories.
ABT: 46.09 (+0.87), CTRX: 53.24 (+0.65), OCR: 76.89 (+0.14), AHS: 20.56 (-0.34)
Doug Loe: Canada Has Earned Its Spot In The Biotech All-Star Team Photo
Life Sciences Report - Seeking Alpha - Fri Dec 19, 9:53AM CST
Biotech investors in the United States who overlook investment opportunities across the borders are missing out on huge opportunities, says Douglas Loe, healthcare equity analyst with Euro Pacific Canada. In this interview with The Life Sciences...
BIIB: 391.66 (-0.45), VRX: 167.00 (-0.50), QLTI: 4.15 (unch), CTRX: 53.24 (+0.65), BCRX: 10.06 (-0.09), ACT: 285.37 (+3.71), MDT: 75.26 (+0.33), TKMR: 21.45 (-0.22), NEPT: 1.83 (+0.06), BSX: 14.98 (+0.24), AGN: 229.49 (+1.87), CMRX: 40.16 (+0.08), ALNY: 95.54 (+1.67), SRPT: 12.76 (+0.11), SHPG: 239.82 (+6.11), NLNK: 38.84 (+1.51), SNY: 49.42 (+0.82), MSLI: 1.96 (+0.08), NVCN: 9.08 (-0.17), CRME: 9.76 (-0.14), EBS: 28.76 (-0.12), GSK: 47.94 (+1.99), CELG: 115.88 (+0.16), GILD: 101.90 (+1.10), MRK: 58.81 (-0.07), NVDQ: 15.12 (+0.51), NVS: 102.20 (-0.17)
Health Care Services Equities Technical Commentary - Express Scripts Holding, DaVita HealthCare Partners, Omnicare, Laboratory Corp. of America, and Catamaran
PR Newswire - Mon Dec 08, 7:45AM CST
Investor-Edge has initiated coverage on the following equities: Express Scripts Holding Company (NASDAQ:ESRX), DaVita HealthCare Partners Inc. (NYSE: DVA), Omnicare Inc. (NYSE: OCR), Laboratory Corporation of America Holdings (NYSE: LH), and Catamaran Corporation (NASDAQ: CTRX). Free research on these five companies can be accessed at: http://investor-edge.com/register. On Friday, December 05, 2014, the NASDAQ Composite ended at 4,780.76, up 0.24%, the Dow Jones Industrial Average advanced 0.33%, to finish the day at 17,958.79, and the S&P 500 closed at 2,075.37, up 0.17%. During the session five out of ten sectors ended in positive. The S&P 500 Health Care Sector Index ended the day at 817.34, up 0.77%, with the index also advancing 5.43% in the last one month. Register for your complimentary reports on these five stocks at:
CTRX: 53.24 (+0.65), OCR: 76.89 (+0.14), ESRX: 84.90 (+0.40), DVA: 73.10 (-3.29), LH: 116.90 (+0.06)
Catamaran to present at the Bank of America Merrill Lynch 2014 Leveraged Finance Conference
PR Newswire - Wed Nov 26, 7:15AM CST
Catamaran Corp. (NASDAQ: CTRX) (TSX: CCT), a leading provider of technology and pharmacy benefit management (PBM) services, announces that Mike Shapiro, Chief Financial Officer, will present at the Bank of America Merrill Lynch 2014 Leveraged Finance Conference in Boca Raton, FL. Catamaran's presentation will take place on Wednesday, December 3, 2014, at 8:10 a.m. ET.
CTRX: 53.24 (+0.65), CCT.TO: 66.31 (+0.61)
